Compare QURE & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | TRMD |
|---|---|---|
| Founded | 1998 | 1889 |
| Country | Netherlands | United Kingdom |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2013 | 2016 |
| Metric | QURE | TRMD |
|---|---|---|
| Price | $24.11 | $36.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $59.78 | $44.50 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 14.25% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $44.21 | $50.31 |
| Revenue Next Year | $398.45 | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.73 | $19.30 |
| 52 Week High | $51.72 | $43.31 |
| Indicator | QURE | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 46.60 |
| Support Level | $20.63 | $28.62 |
| Resistance Level | $26.01 | $38.73 |
| Average True Range (ATR) | 1.93 | 1.57 |
| MACD | 0.68 | -0.51 |
| Stochastic Oscillator | 57.62 | 35.45 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
TORM PLC operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha, and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.